Handel nachbörslich: 10.36

Enanta Pharmaceuticals Inc (ENTA)

Enanta Pharmaceuticals Inc Aktie (ENTA) Neueste Nachrichten

Enanta Pharmaceuticals Inc (ENTA)

Enanta Pharmaceuticals Inc Aktie (ENTA) Neueste Nachrichten

Enanta shares hold as Baird affirms target on new data By Investing.com - Investing.com Canada

Enanta’s Phase II Challenge Data Position A Second Potential RSV Therapy - Scrip

Enanta Pharmaceuticals (NASDAQ:ENTA) Rating Reiterated by JMP Securities - MarketBeat

Rhumbline Advisers Increases Position in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - Defense World

Enanta’s next RSV pill raises ‘high bar set by zelicapavir’ - The Pharma Letter

Enanta reports promising results for RSV drug EDP-323 - Investing.com

Enanta Pharmaceuticals Reports Antiviral For Respiratory Syncytial Virus Reduces Virus Levels, Symptoms In Study - Benzinga

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Shares Sold by Armistice Capital LLC - MarketBeat

Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (RSV) - StockTitan

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Shares Bought by Bank of New York Mellon Corp - Defense World

Enanta Pharmaceuticals Inc [ENTA] Chief Medical Officer makes an insider sale of 5,375 shares worth 91,805. - Knox Daily

Is Enanta Pharmaceuticals Inc (ENTA) a good investment opportunity? - US Post News

Gaining Ground: Enanta Pharmaceuticals Inc (ENTA) Closes Lower at 11.30, Down -0.79 - The Dwinnex

(ENTA) Investment Analysis - Stock Traders Daily

Envestnet (NYSE:ENV) Earns "Neutral" Rating from DA Davidson - MarketBeat

Rhumbline Advisers Raises Stock Holdings in Enovix Co. (NASDAQ:ENVX) - Defense World

Enel Chile (NYSE:ENIC) Trading Down 2.6% - MarketBeat

Smart Money Is Betting Big In ENVX Options - Benzinga

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Stock Traders Buy Large Volume of Put Options on Enovix (NASDAQ:ENVX) - MarketBeat

Enovix Co. (NASDAQ:ENVX) Shares Acquired by Oppenheimer & Co. Inc. - Defense World

Enel Chile S.A. (NYSE:ENIC) Short Interest Up 52.1% in August - Defense World

Principal Financial Group Inc. Increases Holdings in Enovix Co. (NASDAQ:ENVX) - Defense World

Rhumbline Advisers Sells 6,177 Shares of Enova International, Inc. (NYSE:ENVA) - Defense World

ENVX Stock Sees Surge of Approximately 14.60% in Last Five Days - Knox Daily

Acadian Asset Management LLC Has $11.01 Million Holdings in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - Defense World

Insiders Relieved After Selling Enanta Pharmaceuticals With 10% Price Dip - Simply Wall St

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Short Interest Update - MarketBeat

ENTAEnanta Pharmaceuticals, Inc Latest Stock News & Market Updates - StockTitan

Objective long/short (ENTA) Report - Stock Traders Daily

Enanta Pharmaceuticals to Participate in Investor Conferences in September - Business Wire

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives $19.00 Consensus Target Price from Analysts - MarketBeat

California State Teachers Retirement System Trims Stake in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - Defense World

ENTA (Enanta Pharmaceuticals) Net Issuance of Preferred Sto - GuruFocus.com

Assenagon Asset Management S.A. Lowers Holdings in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - MarketBeat

ENTA (Enanta Pharmaceuticals) EPS without NRI : $-5.45 (TTM As of Jun. 2024) - GuruFocus.com

Enanta Pharmaceuticals (STU:9EP) Revenue per Share : €3.15 (TTM As of Jun. 2024) - GuruFocus.com

Enanta Pharmaceuticals (STU:9EP) Price-to-Owner-Earnings : (As of Aug. 18, 2024) - GuruFocus.com

Enanta Pharmaceuticals (STU:9EP) Momentum Rank : 10 (As of Aug. 17, 2024) - GuruFocus.com

ENTA (Enanta Pharmaceuticals) 50-Day SMA : $13.59 (As of Aug. 17, 2024) - GuruFocus.com

Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Passes Below 200-Day Moving Average of $13.75 - MarketBeat

Enanta Pharmaceuticals (STU:9EP) Financial Strength : 5 (As of Jun. 2024) - GuruFocus.com

Enanta Pharmaceuticals (STU:9EP) FCF Yield % : -38.81 (As of Aug. 19, 2024) - GuruFocus.com

Enanta Pharmaceuticals (STU:9EP) 5-Year Dividend Growth Rat - GuruFocus.com

Enanta Pharmaceuticals (STU:9EP) Float Percentage Of Total Shares Outstanding : 94.00% (As of Aug. 17, 2024) - GuruFocus.com

Enanta Pharmaceuticals (STU:9EP) Volatility : 63.41% (As of Aug. 19, 2024) - GuruFocus.com

ENTA (Enanta Pharmaceuticals) 50-Day SMA : $13.59 (As of Aug. 16, 2024) - GuruFocus.com

ENTA (Enanta Pharmaceuticals) 3-Year Dividend Growth Rate : 0.00% (As of Jun. 2024) - GuruFocus.com

ENTA (Enanta Pharmaceuticals) EV-to-Revenue : 0.91 (As of Aug. 16, 2024) - GuruFocus.com

ENTA (Enanta Pharmaceuticals) Debt-to-Revenue : 0.70 (As of Jun. 2024) - GuruFocus.com

ENTA (Enanta Pharmaceuticals) Investments And Advances : $42.51 Mil (As of Jun. 2024) - GuruFocus.com

Enanta Pharmaceuticals Inc (ENTA) Becoming More Attractive for Investors - Knox Daily

(ENTA) Trading Report - Stock Traders Daily

Enanta Pharmaceuticals, Inc. (ENTA): Caligan Partners’ Top Holding Right Now? - Insider Monkey

Enanta Pharmaceuticals, Inc. (ENTA): Caligan Partners’ Top Holding Right Now? - Yahoo Finance

Vanguard Group Inc. Boosts Stake in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - Defense World

Vanguard Group Inc. Has $33.66 Million Stock Holdings in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - MarketBeat

Top 10 Holdings of Caligan Partners - Insider Monkey

Enanta Pharmaceuticals (NASDAQ:ENTA) Upgraded to “Strong-Buy” by Evercore ISI - Defense World

HC Wainwright Equities Analysts Increase Earnings Estimates for Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - Defense World

Research Analysts Set Expectations for Enanta Pharmaceuticals, Inc.’s FY2024 Earnings (NASDAQ:ENTA) - Defense World

Evercore ISI Upgrades Enanta Pharmaceuticals (NASDAQ:ENTA) to "Strong-Buy" - MarketBeat

HC Wainwright Research Analysts Boost Earnings Estimates for Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - MarketBeat

Here's What Analysts Are Forecasting For Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) After Its Third-Quarter Results - Simply Wall St

Understanding the Risks of Investing in Enanta Pharmaceuticals Inc (ENTA) - Knox Daily

Enanta Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Enanta Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Public Employees Retirement System of Ohio Sells 24,735 Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - Defense World

Virtu Financial LLC Purchases New Shares in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - Defense World

Ähnlich wie ENTA